Next Generation Sequencing Market Scope
The global next generation sequencing market can reach a valuation of USD 20,347.45 million by 2023. It is predicted to expand at a CAGR of 18.05% over the forecast period. Major factors driving market growth include growth of genome mapping programs, advanced in diagnostic kits, and technological advances in genomics and molecular biology. Huge demand for personalized medicine owing to the alarming cases of chronic diseases such as cancer can fuel the market demand. Advantages of NGS over Sanger sequencing in terms of reading speed, low sample size, accuracy, and cost can drive the market demand.
However, ethical issues pertaining to genome sequencing, lack of awareness, and difficulties in management of large volumes of data can hamper the market growth.
Next Generation Sequencing Market Segmentation
The global next-generation sequencing market has been segmented into technology, workflow, application, and end user.
Based on technology, the global next-generation sequencing market has been divided into whole-genome sequencing, whole-exome sequencing, and targeted sequencing & resequencing. The targeted sequencing & resequencing segment has been further divided into DNA-based targeted sequencing & resequencing and RNA-based targeted sequencing & resequencing.
Based on workflow, the global next-generation sequencing market has been divided into pre-sequencing, sequencing, and data analysis. The pre-sequencing segment has been further segmented into NGS-semi-automated library preparation kits, NGS library preparation kits, NGS automated library preparation kits, and clonal amplification. The data analysis segment is further segmented into NGS primary data analysis, NGS secondary data analysis, and NGS tertiary data analysis.
Applications of the market comprise agrigenomics & forensics, oncology, human leukocyte antigen typing or immune system monitoring, drug development, clinical investigation, reproductive health, metagenomics, epidemiology, consumer genomics, and others. The oncology segment has been sub-segmented into companion diagnostics, diagnostics & screening, oncology screening, and others. The clinical investigation segment has been further segmented into non-communicable diseases, infectious diseases, inherited diseases, idiopathic diseases, and others. The reproductive health segment has been further divided into newborn or genetic screening, non-invasive prenatal testing, pre-implantation genetic testing, and single-gene analysis.
End-users of the market are pharmaceutical and biotechnology companies, hospitals & clinics, diagnostic laboratories, and others.
Market Highlights
There are various diseases that have their roots in genetics such as cancer, diabetes, Alzheimer’s, arthritis, heart disease, etc. To discover viable treatment for these diseases, researchers are looking to discern how genes work. The next-generation sequencing market has been gaining impetus due to the fact that next-generation sequencing is integral to the field of genomics. The NGS technologies are implemented for several applications, including whole-genome sequencing, de novo assembly sequencing, resequencing, and transcriptome sequencing at the DNA or RNA level. The successful application of next-generation sequencing can lead to predicting genes, protein-coding regions, and pathways.
Next Generation Sequencing Market Regional Analysis
Americas, Europe, Asia Pacific (APAC), and the Middle East & Africa (MEA) are regions taken into consideration with respect to the global next generation sequencing market.
Americas held the largest market share owing to advances in sequencing, applications in genomics, and availability of funds for research and development. Utilization of phylogenetic markers for the study of microbial cultures will favor the regional NGS market.
Market Analysis
Global Next Generation Sequencing Market Size is expected to exhibit significant growth over the forecast period. The NGS Market Growth is projected to register a CAGR of 18.05% over the forecast period to reach USD 20,347.45 Million by 2025.
Next Generation Sequencing Market Competition Outlook
BGI, Agilent Technologies, Inc., F. Hoffmann-La Roche Ltd, Charles River, Illumina, Inc., PerkinElmer Inc., Oxford Nanopore Technologies, Genome Life Sciences, Thermo Fisher Scientific, GenScript, Pacific Biosciences of California, Inc., Qiagen, Xcelris Genomics, Macrogen, Inc., and Eurofins Scientific are key players of the global next generation sequencing market.
Europe can hold the second position in the Next generation sequencing market share owing to the focus of molecular research companies for developing better products.
APAC is predicted to showcase a robust growth rate during the forecast period due to technological breakthroughs in sequencing and investments by healthcare companies for developing accurate diagnostic testing kits. Full genome sequencing was used in the isolation of the COVID-19 pathogen from patients and the virus strain was replicated in Vero cells for further study.
Next Generation Sequencing Industry News
Roche decided to acquire Stratos Genomics for developing its nanopore sequencing technology. The technology of the latter can assist Roche for attaining DNA samples for individual genetic disorders.
Obtain Premium Research Report Details, Considering the impact of COVID-19 @ https://www.marketresearchfuture.com/reports/next-generation-sequencing-market-6354
Read More Similar Reports Like:
Atopic Dermatitis Market Research Report- Global Forecast till 2027
Dental Implants Market Research Report - Global Forecast till 2027
Lung Cancer Market Research Report - Global Forecast till 2027
About Market Research Future:
At Market Research Future (MRFR) , we enable our customers to unravel the complexity of various industries through our Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), Raw Research Reports (3R), Continuous-Feed Research (CFR) ), and Market Research & Consulting Services.
